4.92
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Nyxoah announces shareholding changes as Robert Taub surpasses 10% threshold - MSN
Nyxoah Announces Shareholding Changes as Robert Taub Surpasses 10% Threshold - TipRanks
How Nyxoah SA (5YI) stock compares with tech leadersWeekly Stock Analysis & Community Verified Trade Signals - Newser
Will Nyxoah SA stock outperform international peersIPO Watch & Accurate Technical Buy Alerts - Newser
Is Nyxoah SA stock a buy for dividend growthJuly 2025 Levels & Risk Controlled Daily Plans - Newser
Will Nyxoah SA (5YI) stock remain on Wall Street radar2025 Institutional Moves & Reliable Breakout Forecasts - Newser
Nyxoah (NYXH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Publication relating to transparency notifications - marketscreener.com
Can Nyxoah SA (5YI) stock sustain institutional flowsJuly 2025 Intraday Action & Daily Chart Pattern Signals - Newser
What MACD trends signal for Nyxoah SA (5YI) stock2025 Dividend Review & Verified Entry Point Signals - Newser
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System - sharewise.com
Nyxoah’s Genio Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule - Sleep Review
Why Nyxoah SA stock is recommended by analystsTrade Entry Report & AI Driven Stock Price Forecasts - moha.gov.vn
How Nyxoah SA stock performs in high volatility marketsRecession Risk & Trade Opportunity Analysis Reports - moha.gov.vn
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire
Nyxoah receives Medicare reimbursement increases for Genio - MSN
Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy - MSN
Nyxoah S.A. (NASDAQ:NYXH) Q3 2025 Earnings Call Transcript - MSN
Nyxoah’s Genio therapy gets significant 2026 Medicare reimbursement increases under final CMS rule - MSN
Nyxoah Notes Higher US Reimbursements for Genio Implant Procedures in 2026 - marketscreener.com
01 Communique (TSXV: ONE) teams with Turnium to expand IronCAP X quantum-safe email - Stock Titan
Nyxoah SA (NYXH) Q3 2025 Earnings Call Highlights: Strong US Launch and Strategic Expansion ... By GuruFocus - Investing.com Canada
Will Supply Chain Issues Impact Indian Toners Developers Limiteds PerformanceExit Strategy Tips & High Profit Investment Ideas - earlytimes.in
Will Nyxoah SA (5YI) stock extend growth storyCPI Data & Accurate Technical Buy Alerts - newser.com
Can Nyxoah SA stock sustain free cash flow growth2025 Key Lessons & Free Real-Time Market Sentiment Alerts - newser.com
Why Nyxoah SA (5YI) stock attracts wealthy investorsIndex Update & Consistent Growth Equity Picks - newser.com
Nyxoah (NASDAQ: NYXH) Reports 43,026,460 Voting Rights and Share Capital Update - Stock Titan
Why Nyxoah SA stock is seen as undervaluedJuly 2025 Decliners & Low Drawdown Investment Strategies - newser.com
Can Nyxoah SA stock sustain market leadershipJuly 2025 Market Mood & AI Forecasted Stock Moves - newser.com
Information on the total number of voting rights and shares - GlobeNewswire
Should I buy Nyxoah SA (5YI) stock before earnings seasonWeekly Risk Report & Daily Chart Pattern Signals - newser.com
How Nyxoah SA (5YI) stock trades under stagflation2025 EndofYear Setup & Safe Capital Investment Plans - newser.com
How Nyxoah SA (5YI) stock compares with market leaders2025 Support & Resistance & Momentum Based Trading Signals - newser.com
How high can Nyxoah SA stock go2025 Dividend Review & Weekly Setup with ROI Potential - newser.com
Heatmap analysis for Nyxoah SA and competitorsJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Latham DQ'd From Sleep Apnea Device Co.'s Patent Fight - Law360
How Nyxoah SA (5YI) stock trades pre earningsJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com
Can Nyxoah SA (5YI) stock double in coming yearsMarket Rally & Weekly Top Stock Performers List - newser.com
Latham & Watkins Disqualified in Inspire IP Suit Against Nyxoah - Bloomberg Law News
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):